From: Exploring why patients in heroin-assisted treatment are getting incarcerated—a qualitative study
n | % | M | SD | ||
---|---|---|---|---|---|
Sociodemographic characteristics | |||||
Sex | female | 3 | 13.6 | ||
male | 19 | 86.4 | |||
Age | 45.14 | 6.94 | |||
Nationality | Switzerland | 17 | 77.3 | ||
Other | 5 | 22.7 | |||
Living situation | rented apartment | 12 | 54.5 | ||
care home | 8 | 36.4 | |||
assisted living | 2 | 9.1 | |||
Source of income | social welfare | 12 | 54.5 | ||
invalidity insurancea | 10 | 45.5 | |||
employment | - | - | |||
Relationship status | single | 11 | 50.0 | ||
in a relationship | 10 | 45.5 | |||
divorced | 1 | 4.5 | |||
Treatment variables | |||||
Length of treatment in the centre | < 1 year | - | - | ||
1–5 years | 9 | 40.9 | |||
6–10 years | 5 | 22.7 | |||
11–15 years | 4 | 18.2 | |||
16–20 years | 2 | 9.1 | |||
> 20 years | 2 | 9.1 | |||
Psychiatric medication at the time of study conduction | diacetylmorphine | 21 | 95.5 | ||
morphine-sulfate | 19 | 86.4 | |||
methadone | 2 | 9.1 | |||
levomethadone | 1 | 4.5 | |||
benzodiazepines | 13 | 59.1 | |||
stimulants | 4 | 18.2 | |||
Route of DAM administration | intravenous | 10 | 45.5 | ||
oral | 6 | 27.3 | |||
oral and intravenous | 5 | 22.7 | |||
not applicableb | 1 | 4.5 | |||
Psychiatric disorders (lifetime prevalence as documented in the patient file) | |||||
Opioid Use Disorder | 22 | 100 | |||
Cocaine Use Disorder | 21 | 95.5 | |||
Alcohol Use Disorder | 8 | 36.4 | |||
Sedative, Hypnotic and Anxiolytic Use Disorder | 7 | 31.8 | |||
Personality Disorders | 5 | 22.7 | |||
Cannabis Use Disorder | 4 | 18.2 | |||
ADHD | 4 | 18.2 | |||
Major Depression | 4 | 18.2 | |||
Schizophrenia | 3 | 13.6 | |||
Anxiety Disorders | 2 | 9.1 | |||
Disruptive Mood Dysregulation Disorder | 1 | 4.5 | |||
Bipolar Disorder | 1 | 4.5 |